Biomeva

Heidelberg, Germany Founded: 1993 • Age: 33 yrs Acquired By AGC Group
Serves as a CMO for CGMP production of biologics and therapeutic proteins via microbial fermentation.

About Biomeva

Biomeva is a Healthcare company based in Heidelberg (Germany) founded in 1993, and was acquired by AGC Group in September 2016. It serves as a CMO for CGMP production of biologics and therapeutic proteins via microbial fermentation. It operates on a B2B model. Its focus areas include Biotechnology, Pharmaceutical Manufacturing and Biologics Production. Its competitors include Wacker Chemie and Vibalogics.

Company details

Biomeva, founded in 1993 in Heidelberg, Germany, focuses on providing healthcare solutions, advancing biotech innovations, pharmaceutical manufacturing, and biologics production. Serves as a CMO for CGMP production of biologics and therapeutic proteins via microbial fermentation. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.

  • Headquarters Heidelberg, Germany
  • Stage Acquired
  • Sectors
    Healthcare
  • Website biomeva.com
  • Acquired by AGC Group (Sep 2016)
Key Metrics

Investors in Biomeva

Biomeva has secured backing from 1 investor. Prominent investors backing the company include AGC Group.

All
InvestorDescriptionFounded YearDomainLocation
Glass solutions, chemicals, and high-tech materials are supplied worldwide.
1907agc-group.comChiyoda City, Japan
Premium access

Investor details for Biomeva

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Biomeva

2 dated milestones of Biomeva across 23 years, from founding to its latest funding, stage changes and deals.

  1. Founded Biomeva is founded.
  2. Exit Acquired by AGC Group.

Competitors of Biomeva

Biomeva has 2 listed competitors in our database. They include Wacker Chemie and Vibalogics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
wacker.com1914Munich, Germany1,509
Silicones, polymers, and bio-solutions are manufactured for various industries.
vibalogics.com2007Cuxhaven, Germany89
CDMO offering development, cGMP manufacturing and fill/finish of biologics based on viruses and bacteria
Premium access

Detailed competitors of Biomeva

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Biomeva

Biomeva was founded in 1993.

Biomeva is headquartered in Heidelberg, Germany. It is registered at Heidelberg, Baden-wurttemberg, Germany.

Biomeva, founded in 1993 in Heidelberg, Germany, focuses on providing healthcare solutions, advancing biotech innovations, pharmaceutical manufacturing, and biologics production. Serves as a CMO for CGMP production of biologics and therapeutic proteins via microbial fermentation. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.

Biomeva's top competitors include Wacker Chemie and Vibalogics.

Biomeva has 1 investor. Key investors include AGC Group.

Yes. Biomeva was acquired by AGC Group in September 2016.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available